| Fund Name | Location |
| 3L Capital | California, Los Angeles, United States |
| 5square | Laren, Noord-Holland, The Netherlands |
| AfterDox | HaMerkaz, Israel, Kfar Saba |
| Asia Internet Investment Group | - |
| Cell Capital | England, London, United Kingdom |
| DeepSky Capital | China, Hong Kong, Hong Kong Island |
| Delta Link Capital | Beijing, Beijing, China |
| Duke Management Company | Durham, North Carolina, United States |
| Fuzhou Zhengtong Touzi Youxian Gongsi | China, Foochow, Fujian |
| Huaqing Bencao Investment Management | China, Jiangsu, Nantong |
| Innobridge | Neuchatel, Neuchâtel, Switzerland |
| KKBOX Group | - |
| Michaelson Capital Partners | New York, New York, United States |
| Momentum Fund | - |
| Ohara Pharmaceutical | Japan, Koka, Shiga Prefecture |
| Shenzhen Gemboom Investment Management | China, Guangdong, Shenzhen |
| Shenzhen Zhongrun Huixian Investment Management | China, Guangdong, Shenzhen |
| Urban Capital Network | Houston, Texas, United States |
| Xinjiang Zhongyi Wenhua | Changji, China, Xinjiang |
| Zhongfu Investment Group | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Jiadong Health | $2M | 08 Aug 2018 | Futian District, Guangdong Province, China | ||
Pengyang Medical | $3M | 24 Jul 2018 | Dongcheng District, Beijing, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Jiadong Health | $2M | 08 Aug 2018 | Futian District, Guangdong Province, China | ||
Pengyang Medical | $3M | 24 Jul 2018 | Dongcheng District, Beijing, China |
